NCT03259867 2026-04-16
TATE-PD1
Teclison Ltd.
Phase 2 Recruiting
Clinical Trials
27 trialsNCT07498413 2026-04-01
ROTOR
Novartis
Completed
NCT06635447 2026-03-27
CAPItrue
AstraZeneca
Phase 3 Active not recruiting
NCT04678648 2026-03-18
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
Phase 1 Recruiting
NCT07049055 2026-02-27
Carolyn-USA
Engeneic Pty Limited
Phase 1/2 Recruiting
NCT02270567 2025-11-13
RegisterNET
Wren Laboratories LLC
Enrolling by invitation
NCT04987203 2025-08-22
Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma
AVEO Pharmaceuticals, Inc.
Phase 3 Active not recruiting
NCT02533258 2025-07-16
Post-Marketing Surveillance Study To Observe INLYTA® Treatment Dosing Pattern, Safety And Effectiveness In Taiwan Real World Routine Practice
Pfizer
Completed
NCT05153330 2025-07-03
Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL
Biomea Fusion Inc.
Phase 1 Terminated
NCT05712356 2025-06-06
BOLSTER
Lisata Therapeutics, Inc.
Phase 2 Active not recruiting
NCT02766699 2025-06-03
CerebralEDV
Engeneic Pty Limited
Phase 1 Completed
NCT04503265 2025-05-01
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
AtlasMedx, Incorporated
Phase 1/2 Recruiting
NCT02392078 2025-04-24
LAANTERN
Monteris Medical
Completed
NCT04436120 2024-12-03
TRANSLATE
Pfizer
Phase NA Terminated
NCT05551013 2024-08-09
Treatment of Recurrent GBM With APG-157 Via Expanded Access
Aveta Biomics, Inc.
No longer available
NCT01651078 2024-04-15
LAASR
Monteris Medical
Completed
NCT02389855 2024-04-12
Laser Ablation in Stereotactic Neurosurgery (LAISE): NeuroBlate® Retrospective Registry
Monteris Medical
Completed
NCT02189343 2019-11-21
Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed-and-Refractory Multiple Myeloma
Celgene
Phase 1 Completed
NCT02586987 2019-11-18
A Study to Assess the Safety, Tolerability and Anti-tumour Activity of Ascending Doses of Selumetinib in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid Tumours
AstraZeneca
Phase 1 Completed
NCT03804866 2019-01-15
NGR-hTNF in Combination With an Anthracycline in Platinum-resistant Ovarian Cancer (NGR018)
AGC Biologics S.p.A.
Phase 2 Completed
NCT01358071 2018-09-27
NGR018
AGC Biologics S.p.A.
Phase 2 Completed
NCT03150602 2017-05-12
A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy
Taiwan Mundipharma Pharmaceuticals Ltd.
Phase 4 Unknown
NCT01110668 2017-02-28
Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)
Novartis
Phase 2 Completed
NCT00908232 2015-01-15
SEQUENTIAL
Janssen-Cilag International NV
Phase 2 Completed
NCT01692262 2014-06-19
PYRUS
AstraZeneca
Phase 1 Completed
NCT01715155 2013-08-22
Management of Metastatic Breast Cancer in Clinical Practice - Retrospective Study
AstraZeneca
Completed
NCT00171925 2012-04-11
Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I
Novartis
Phase 3 Terminated